Statins benefit leukemia patientsClinical trials needed to pinpoint ideal candidates Dabigatran lowers deep vein clot riskNewer drug compares well with warfarin and does not require lab monitoring Natural products targeting diabetes vary in value While products in question seem safe, not all boast effectiveness. Nilotinib bests imatinib in chronic myeloid leukemia Questions about tolerability and cost of treatment need answering before clinical practice should change Mystery miscarriages not helped by anticoagulation Trial debunks treatment that has become popular for unexplained fetal loss despite lack of evidence Caution eases over using antivirals for pandemic H1N1 Chemo- trastuzumab combo ups survival Fish oil fends off psychosis in high-risk patients Oral drugs may hold new hope for MS patients Ease of use is attractive, but questions remain over what longer-term use will show about side-effects Radial approach lessens kidney risk: B.C. study Doing cardiac catheterization through the wrist has advantages over femoral access, although it is more technically challenging First Previous 1173 1174 1175 1176 1177 Next Last
